Every Form 4 that Amphenol Corporation (APH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow APH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full APH filings page.
Amphenol Corp EVP & CFO Craig A. Lampo reported a bona fide gift of 54,547 shares of Class A Common Stock on 2026-08-06, transferred from the indirect holding “Craig A. Lampo 2024 GRAT #1,” which now reports zero shares.
After this gift, Lampo reports 90,665 shares held directly and additional indirect holdings of 44,947, 70,000, and 118,754 shares in separate GRAT entities.
Amphenol executive David M. Silverman, EVP, Human Resources, reported an option exercise and share sale on August 5, 2026. He exercised stock options to acquire 120,000 shares of Class A Common Stock at $21.995 per share, then sold 120,000 shares at a weighted average price of $174.2373 in multiple trades ranging from $174.00 to $174.50. Following these transactions, 10,828 shares are held indirectly through the David Michael Silverman 2025 GRAT #1.
Amphenol EVP & CFO Craig A. Lampo exercised stock options for 193,200 shares of Class A Common Stock at an exercise price of $22.3725 per share on August 4, 2026. He acquired 193,200 shares and then sold 193,200 shares at a weighted average price of $167.3093 per share in multiple trades ranging from $166.53 to $168.00. The acquired shares include 19,758 shares transferred from his 2024 #1 GRAT since his prior Form 4. He also reports indirect holdings through several GRATs, including 44,947 and 70,000 shares in two 2025 GRATs.
Lance E. D’Amico, EVP, Secretary & General Counsel of Amphenol, reported exercising stock options for 100,000 shares of Class A Common Stock on 2026-08-03 at exercise prices of $22.3725 and $22.5525 per share, then selling 100,000 shares (directly and via the Lance E. D’Amico 2024 Irrevocable Trust) at weighted average prices of $161.9874 and $161.8175 per share in multiple trades ranging from $161.06 to $162.1210. Indirect holdings reported include 19,335 shares in a 2025 GRAT and 25,000 shares in a 2026 GRAT.
Amphenol President & CEO Richard Adam Norwitt exercised stock options covering 686,104 shares of Class A Common Stock at a strike price of $22.3725 per share and sold the resulting shares.
He sold 500,000 shares held directly at a weighted average price of $161.5748 and 186,104 shares held through the Norwitt Family Trust at a weighted average price of $162.2712. He continues to hold stock options for 399,788 shares directly.
Amphenol Corp (APH) executive Luc Walter reported a new stock option grant and updated share holdings. He received stock options for 108,809 shares of Class A Common Stock at an exercise price of $132.06 per share, expiring on May 22, 2036.
The options begin vesting on May 22, 2027 and become exercisable at 20% per year over five years. Following this filing, Walter directly holds 353,742 shares of Class A Common Stock, indicating a substantial ongoing equity stake in the company in addition to the new option award.
Amphenol Corp executive Peter Straub, President of the ISS Division, received a grant of stock options covering 108,809 shares of Class A Common Stock. The options have an exercise price of $132.0600 per share, vest 20% per year over five years starting on the first anniversary of the grant date, and expire on May 22, 2036. Following this award, the filing shows 108,809 stock options outstanding for Straub.
Amphenol Corporation executive David M. Silverman received a new stock option award tied to the company’s Class A Common Stock. On May 22, 2026, he was granted options for 70,690 shares at an exercise price of $132.06 per share, with no cash paid at grant.
The options become exercisable 20% per year over a five-year period starting on the first anniversary of the grant date and expire on May 22, 2036. This award is a compensation-related equity grant rather than an open-market purchase or sale.
Following the reported positions, Silverman holds 15,672 Amphenol Class A shares directly, which includes 3,172 shares transferred from his 2025 GRAT #1 since his last Form 4, and 10,828 shares indirectly through the David Michael Silverman 2025 GRAT #1, along with the newly granted 70,690 stock options.
Amphenol Corp President & CEO Richard Adam Norwitt reported a new stock option grant on Class A Common Stock. He received options covering 464,989 shares at an exercise price of 132.06 per share, exercisable starting on the first anniversary of the grant date.
According to the filing, the options vest at 20% per year over five years and expire on May 22, 2036. The report also lists existing holdings of Class A Common Stock held directly, indirectly through the Norwitt Family Trust, and some shares owned through his IRA, with no open-market buys or sells disclosed.
Amphenol Executive VP & CFO Craig A. Lampo reported updated holdings and a new equity award. He received a grant of 133,161 stock options on Class A Common Stock at an exercise price of $132.06 per share, expiring in 2036. The options begin to vest 20% per year over five years starting on the first anniversary of the grant date, aligning compensation with longer-term performance. The filing also lists his direct holding of 70,907 Class A shares and additional indirect holdings through several GRAT entities.
Ivas Michael R. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corp senior vice president and corporate controller Michael R. Ivas reported a new stock option grant linked to the company’s Class A Common Stock. He received options covering 51,134 shares, exercisable at $132.06 per share, expiring in 2036.
According to the footnote, these options become exercisable at 20% per year over five years, starting on the first anniversary of the grant date. The filing also lists his existing share positions, including 154,948 shares held directly and additional indirect holdings through his spouse, children, and a 2026 GRAT.
Amphenol Corp executive William J. Doherty, President of the CS Division, received a grant of stock options as part of his compensation. He was awarded 108,809 stock options, each giving the right to buy one share of Class A Common Stock at an exercise price of $132.06 per share.
The options start to become exercisable at a rate of 20% per year over five years, beginning on the first anniversary of the grant date, and will expire on May 22, 2036. The filing also shows that Doherty held 0 shares of Class A Common Stock directly after the reported transactions.
Amphenol EVP and General Counsel Lance E. D'Amico received a stock option award tied to the company’s Class A Common Stock. On May 22, 2026, he was granted options for 83,020 shares at an exercise price of $132.06 per share, vesting 20% per year over five years starting one year after the grant date and expiring on May 22, 2036.
Following this filing, D'Amico is reported as holding 57,065 shares of Class A Common Stock directly, plus 25,000 shares and 19,335 shares indirectly through the Lance E. D'Amico 2026 GRAT #1 and 2025 GRAT #1, respectively.
Wolff Anne Clarke reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Anne Clarke Wolff received a grant of 1,552 shares of Restricted Stock. The award was granted on May 22, 2026 at a stated price of $0.0000 per share as compensation, not a market purchase.
The grant was made under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. Following this award, Wolff directly holds 1,552 shares of Restricted Stock and 41,154 shares of Class A Common Stock reported as a holding entry.
Singh Prahlad R. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Prahlad R. Singh received a grant of 1,552 shares of Restricted Stock. The award was granted at a price of $0.0000 per share under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
Following this filing, Singh holds 11,376 shares of Class A Common Stock directly and 1,552 shares of Restricted Stock directly. The grant reflects equity-based compensation for his role as a director rather than an open-market purchase or sale.
Livingston Robert reported acquisition or exercise transactions in this Form 4 filing.
Amphenol director Robert Livingston received an award of 1,552 shares of Restricted Stock on May 22, 2026. The grant was made at $0.00 per share as a compensation award under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
Following the transactions reported, Livingston directly holds 138,080 shares of Class A Common Stock and 1,552 shares of Restricted Stock. The filing reflects a stock grant rather than any open‑market buying or selling activity.
Amphenol director Rita S. Lane reported a new equity award and updated holdings. She received 1,552 shares of Restricted Stock of Amphenol Corporation on May 22, 2026 as a grant under the 2024 Restricted Stock Plan for Directors, with no purchase price paid.
Following this award, Lane holds 9,840 shares of Class A Common Stock directly and 15,006 shares indirectly through the Fries Lane Family Living Trust, along with the 1,552 restricted shares. This filing reflects a compensation-related acquisition rather than an open-market transaction.
Lamba Sanjiv reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Sanjiv Lamba reported an equity compensation grant and his existing share holdings. On May 22, 2026, he received 1,552 shares of Restricted Stock as a grant under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. A separate line shows he directly holds 548 shares of Class A Common Stock after the reported transactions.
Falck David P reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director David P. Falck reported a grant of 1,552 shares of Restricted Stock. The award was made on May 22, 2026 at a stated price of $0.00 per share, reflecting stock-based compensation rather than an open-market purchase.
These 1,552 Restricted Stock shares are held directly and were granted under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. In a separate holding entry, Falck is shown with 94,794 shares of Class A Common Stock held directly following the reported transactions.
Altobello Nancy A. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Nancy A. Altobello received a grant of 1,552 shares of Restricted Stock on Class A Common Stock equivalent on May 22, 2026. The award was granted pursuant to the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
The Form 4 also reports a holding-line entry showing 18,842 shares of Class A Common Stock held directly after the reported date. There were no open-market purchases or sales disclosed in this filing; the primary activity is a routine compensation-related stock award.
Amphenol Executive VP & CFO Craig A. Lampo reported estate-planning related changes in his Amphenol holdings. On May 20, 2026, he completed an “other” transaction involving 41,203 shares of Class A Common Stock, leaving 70,907 shares held directly.
On May 19, 2026, he made bona fide gifts of stock options covering 34,499 shares at an exercise price of $86.8800 and 69,108 shares at $65.9550, both tied to Class A Common Stock. A footnote states this reflects a transfer of shares to a family trust for estate planning in exchange for a note, rather than an open-market sale.
Amphenol Corporation executive Lance E. D'Amico reported non-market gift transfers of stock options. On May 20, 2026, he recorded four bona fide gifts of stock options covering a total of 129,188 shares of Amphenol Class A Common Stock, involving both his direct holdings and the Lance E. D'Amico 2024 Irrevocable Trust. The options have exercise prices of $86.88 and $65.955 per share and expire in 2034 and 2035, indicating these are transfers of existing option awards rather than open-market trades.
Amphenol Corp. President & CEO Richard Adam Norwitt exercised stock options and sold shares in a series of transactions. Between May 1–5, 2026, he exercised options to acquire 130,775 shares of Class A Common Stock at an exercise price of $22.3725 per share and sold the same total number of shares in open-market transactions at weighted average prices around $143–$144 per share.
After these transactions, he directly holds 1,927,507 Class A Common shares, in addition to 3,968 shares held through his IRA and 864,177 shares held indirectly by the Norwitt Family Trust.
Amphenol Executive VP & CFO Craig A. Lampo reported an option exercise and share sale. He exercised stock options for 100,000 shares of Class A Common Stock at an exercise price of $21.9950 per share, then sold 100,000 shares in the open market at a weighted average price of $149.9813 per share. After these transactions, he held 112,110 shares directly, with additional indirect holdings, including 39,884 shares held by the Lampo Family Trust and 44,947 shares held by the Craig A. Lampo 2025 GRAT #1.
Amphenol Corporation officer Lance E. D'Amico reported option and share transactions involving the company’s Class A common stock. On February 18, 2026, he exercised stock options for 50,000 shares at an exercise price of $22.5525 per share, converting derivative securities into common stock.
On the same date, he sold 50,000 shares of Class A common stock in open-market transactions at a weighted average price of $149.8831 per share. After these trades, he held 57,065 shares directly, plus 19,335 shares and 25,000 shares indirectly through two GRAT trusts.
Amphenol Corporation’s President and CEO Richard Adam Norwitt reported stock option exercises and related share sales in Class A common stock. On February 12, 2026, options to acquire 515,281 shares and 93,052 shares at an exercise price of $22.3725 were exercised, directly and through the Norwitt Family Trust.
On the same date, the same amounts of Class A common stock—515,281 shares held directly and 93,052 shares held through the trust—were sold in open-market transactions at weighted average prices of $147.2656 and $147.1693, respectively, executed in multiple trades. After these transactions, Norwitt directly held 1,927,507 shares, the Norwitt Family Trust held 864,177 shares, and an additional 3,968 shares were held through his IRA.
Amphenol Corporation director Robert Livingston reported buying additional shares of the company’s Class A Common Stock. On February 5, 2026, he purchased 10,000 shares at a weighted average price of $128.508 per share in multiple trades.
After this transaction, Livingston directly owns 135,720 shares of Amphenol Class A Common Stock, plus 2,360 shares of restricted stock. The price range for the purchases was from $128.2928 to $128.7052, reflecting execution across several individual trades.
Amphenol Corporation VP & Corporate Controller Michael R. Ivas reported multiple equity transactions on Class A Common Stock. On 02/04/2026 he exercised a stock option for 25,000 shares at an exercise price of $22.3725 per share, increasing his directly held stock to 179,948 shares.
That same day, 25,000 shares were reported as a gift directly, reducing his direct holdings to 154,948 shares, and another 25,000 shares were reported as a gift held indirectly by "Michael Ivas 2026 GRAT #1." Additional indirect holdings disclosed were 2,995 shares held by children and 1,700 shares held by spouse. Following the option exercise, he also reported 203,000 stock options beneficially owned.
Amphenol Corporation executive Michael R. Ivas reported a trust distribution of company stock. On January 29, 2026, he acquired 2,536 shares of Class A Common Stock at $0 per share through a distribution from his grantor retained annuity trust for no consideration. Following this transfer, he directly beneficially owned 154,948 shares. The filing also notes indirect ownership of 2,995 shares held by his children and 1,700 shares held by his spouse.
Amphenol Corporation director Sanjiv Lamba reported receiving a grant of restricted stock. On 01/08/2026, he acquired 548 shares of Amphenol restricted stock at a reported price of $136.25 per share under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. Following this award, he beneficially owns 548 shares of Amphenol stock directly.
Amphenol Corporation director reports gift of shares
A director of Amphenol Corporation reported an indirect transfer of Class A Common Stock on 12/10/2025. The filing shows that 3,228 shares of Class A Common Stock were disposed of as a gift by a revocable trust, identified with transaction code “G.” The closing price of the shares on the gift date was $138.68.
After this transaction, the revocable trust beneficially owned 1,333,146 shares of Amphenol Class A Common Stock on an indirect basis. In addition, 2,360 shares are shown as restricted stock awarded under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
Amphenol Corporation (APH) reported an insider transaction by its President and CEO, who is also a director. On 12/09/2025, he reported a transaction coded "G," indicating a gift of 75,000 shares of Class A common stock at a closing price of $138.58 per share. After this transaction, he beneficially owns 1,927,507 Class A shares directly, plus 864,177 shares held by the Norwitt Family Trust and 3,968 shares held through his IRA. This filing shows a transfer of shares rather than a market sale, while maintaining a substantial ongoing ownership stake.
Amphenol Corporation senior vice president and chief financial officer Craig A. Lampo reported an internal reallocation of his holdings in the company’s Class A common stock. On 12/03/2025, he transferred 70,000 shares in a transaction coded "G" (a gift or similar transfer), moving them out of his direct ownership at a stated price of $0 per share. The same number of shares, 70,000, then appeared as indirectly owned through the "Craig A. Lampo 2025 GRAT #2," indicating the shares were placed into a grantor retained annuity trust. After these transactions, Lampo continued to hold additional Amphenol Class A shares indirectly through several trusts, including 2025 GRAT #1, 2024 GRAT #1, 2024 GRAT #2, and the Lampo Family Trust.
Amphenol Corporation executive reports stock option exercise and share sale. On 12/02/2025, an officer of Amphenol Corp (APH), identified as President of the ISS Division, exercised 132,000 stock options for Class A common stock at an exercise price of $22.55 per share. The same day, 132,000 Class A common shares were sold in an open market transaction, classified with code "S," at a weighted average price of $141.8397 per share.
The sale was executed in multiple trades at prices ranging from $141.5200 to $141.9050. After these transactions, the reporting person held 0 shares of Amphenol Class A common stock directly and 44,000 stock options remained beneficially owned as derivative securities.
Amphenol Corporation reported an insider stock transfer by its Senior Vice President and Chief Financial Officer, Craig A. Lampo, on a Form 4. On 11/26/2025, Lampo made a gift of 40,000 shares of Amphenol Class A common stock, reflected with transaction code "G." The closing price on the date of the gift was $138.72 per share.
After this transaction, Lampo beneficially owns 127,695 shares directly. He also has indirect ownership through several entities, including Lampo Family Trust and multiple GRAT (grantor retained annuity) trusts, which together hold additional blocks of Amphenol Class A common stock.
Amphenol Corporation (APH) reported insider derivative transactions by its Senior Vice President of Human Resources on a Form 4. The filing shows stock options on Class A common stock with exercise prices of $37.9 and $65.955 tied to multiple grants. Following the reported transactions dated 11/13/2025, the officer holds option positions both directly and indirectly through the Silverman Family Trust, including option grants over 29,012 and 18,343 underlying shares. These changes reflect reallocation of beneficial ownership between direct and trust accounts rather than new equity issuance by the company.
Amphenol (APH) disclosed insider transactions by its Senior VP & CFO on 11/11/2025. The reporting person exercised 300,000 stock options at $21.995 per share and sold 258,000 Class A shares at a weighted average price of $143.2022. Separately, the Lampo Family Trust exercised 40,076 options at $21.995 and sold 40,076 shares at a weighted average price of $143.5015.
Following these transactions, directly held Class A shares were 167,695. Indirect holdings included 39,884 by the Lampo Family Trust, 58,116 by the Craig A. Lampo 2025 GRAT #1, 74,305 by the 2024 GRAT #1, and 160,000 by the 2024 GRAT #2. Derivative holdings listed 100,000 stock options directly after the reported activity. Prices reflect weighted averages, with trades executed in multiple lots as noted.
Amphenol (APH): A company officer reported an option exercise and share sale. On 11/05/2025, the VP & Corporate Controller exercised stock options for 120,000 Class A shares at $22 (code M), then sold 120,000 shares at a weighted average price of $140.0517 (code S). Following these transactions, the officer beneficially owns 152,412 shares directly, plus 2,995 indirectly by children and 1,700 indirectly by spouse.
The exercised option covered 120,000 shares, first exercisable on 05/18/2019 and expiring on 05/18/2028, and now shows 0 remaining. The sale price reflects multiple trades ranging from $139.5000 to $140.6225, per the issuer’s note.
Amphenol (APH): Senior VP, Human Resources reports option exercise and sale. On 11/03/2025, the reporting officer exercised stock options for 120,000 Class A shares at an exercise price of $21.995 per share and sold 120,000 Class A shares at a weighted average price of $141.1706 (executed in multiple trades between $141.00 and $141.50).
Following these transactions, the officer directly beneficially owned 12,500 Class A shares and indirectly owned 14,000 Class A shares through the David Michael Silverman 2025 GRAT #1. Derivative securities beneficially owned following the transactions were 240,000 stock options with an original exercise price of $21.995 and expiration on 05/18/2028.
Amphenol (APH) reported insider activity by an officer on 10/31/2025. The filer exercised 120,000 stock options at $22 per share and sold 120,000 Class A shares at a $141.3032 weighted average price, executed in multiple trades between $140.85 and $141.5701. Following these transactions, the officer directly owned 152,412 shares. Indirect holdings were 2,995 shares by children and 1,700 by spouse.
Amphenol (APH) insider transaction: An officer identified as President, CS Division reported an option exercise and same‑day sale on 10/29/2025. The filing shows an exercise of 80,000 stock options at an exercise price of $33.295 per share (code M), followed by an open market sale of 80,000 Class A Common shares (code S) at a $141.0366 weighted average price, with trades ranging from $141.00 to $141.1550.
Following these transactions, the filing lists 0 non‑derivative shares beneficially owned and 186,000 derivative securities (stock options) beneficially owned. The stock option series exercised was originally exercisable on 05/20/2022 and expires on 05/20/2031.
Amphenol (APH) reported an insider transaction by its President & CEO and Director on 10/28/2025. The filing shows a bona fide gift of 75,000 Class A Common shares (Code G), and an option exercise (Code M) for 75,000 shares at an exercise price of $22.3725 per share. Following these transactions, the reporting person directly owned 2,002,507 shares. Additional holdings include 864,177 shares held indirectly by the Norwitt Family Trust and 3,968 shares held directly through an IRA. The closing price on the gift date was $137.29.
Amphenol (APH): On 10/29/2025, Sr. VP, Secretary & General Counsel Lance E. D'Amico exercised stock options for 120,000 Class A shares at $22.5525 (code M) and sold 120,000 shares at a weighted average price of $140.0129 (code S), executed across trades ranging from $139.71 to $140.53.
Following these transactions, he directly owned 76,400 shares and indirectly held 25,000 shares via the Lance E. D'Amico 2025 GRAT #1. The exercised options were from a grant first exercisable on 05/21/2021 and expiring on 05/21/2030; 100,000 stock options remained beneficially owned.
Amphenol (APH) reported insider transactions by its HES Division President on 10/24/2025. The officer exercised stock options for 212,800 shares at $33.295 and 152,318 shares at $43.25, then sold the same amounts—212,800 and 152,318 shares—at a weighted average price of $134.6508.
The filing notes the sale price was executed in multiple trades ranging from $133.5000 to $136.8375. In addition, 80,000 shares were reported as gifted, with a closing price on the gift date of $133.82. Following these transactions, the officer directly beneficially owned 353,742 shares. Remaining option balances after the exercises were shown in Table II.